- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01614730
User Evaluation in Healthy Volunteers to Verify no Pelvic Floor Contraction is Stimulated When the Modified Neurotech Vital Device is Used Compared to the Neurotech Vital Device (BMR-12-1002)
July 5, 2012 updated by: Bio-Medical Research, Ltd.
User Evaluation Trial in Healthy Volunteers : Modified Neurotech Vital Device
This user evaluation study is to verify that the Modified Neurotech Vital Device does not stimulate the pelvic floor muscles compared with the Neurotech Vital Device.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
This user evaluation study is to verify that the Modified Neurotech Vital Device does not stimulate the pelvic floor muscles compared with the Neurotech Vital Device.
Stimulation of the pelvic floor muscles will be assessed by using sonographic/real time ultrasound imaging/recording with displacement measurement using onscreen callipers on the sonogram unit to assess contractions.
Study Type
Interventional
Enrollment (Actual)
10
Phase
- Early Phase 1
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
Female
Description
Inclusion Criteria:
Subjects who meet the following inclusion criteria will be included in the study.
- Subjects who are female and at least 18 years of age.
- Subjects who, in the opinion of the Investigator, are deemed healthy.
- Subjects who are able to give voluntary, written informed consent to participate in this study and from whom consent has been obtained.
- Subjects who are able to understand this study and are willing to complete all the study assessments.
Exclusion Criteria:
Subjects who meet any of the following criteria will be excluded from participation in the study.
- Subjects who have an existing medical condition that would compromise their participation in the study.
- Subjects who have a physical condition that would make them unable to perform the study procedures.
- Subjects with a history of any respiratory condition including a chronic cough.
- Subjects with a history of an underlying neurological condition.
- Subjects with a history of low back pain involving the spinal nerve root.
- Subjects with a blood clotting disorder or who are taking anti-coagulant medications.
- Subjects who have previously had any uro-gynaecological related surgery excluding hysterectomy.
- Subjects with a clinical diagnosis of prolapse greater than Stage 2.
- Subjects who are pregnant or could be pregnant.
- Subjects who are less than 6 months post-partum or who are lactating.
- Subjects who have any intra-uterine devices or metal implants in the pelvic area, including hip and lumbar spine.
- Subjects with pelvic pain or fibromyalgia or paravaginal defect.
- Subjects with an active implanted medical device (ie pacemaker, pump etc).
- Subjects with a history of heart disease or stroke.
- Subjects with a known cancer.
- Subjects with an injury or disability affecting any part of their body which will be in contact with the garment.
- Subjects who are currently involved in any injury litigation claims.
- Subjects who have been committed to an institution by virtue of an order issued either by the courts or by an authority.
- Subjects who have participated in a clinical study in the last 3 months.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Allocation: Non-Randomized
- Interventional Model: Crossover Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Sham Comparator: Modified Neurotech Vital Device
Checking to see no contraction is stimulated during treatment with the Modified Neurotech Device
|
verify no contraction is stimulated in the Modified Neurotech Vital.
Other Names:
|
|
Active Comparator: Neurotech Vital Device
Checking to see a contraction is stimulated during treatment of the Neurotech Vital Device
|
Checking there is a contraction of the pelvic floor muscle when the treatment is administered with the Neurotech Vital Device
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Using a sonographic/real time ultrasound imaging machine detect if a contraction is stimulated by the 5 minute treatment with the modified Neurotech Device and 5 minute treatment with the Neurotech Vital Device.
Time Frame: 5 minutes treatment with each device to measure if contraction occurrs on the ultrasound
|
The primary endpoint of the study is to demonstrate that no volunteers elicit a contraction of the pelvic floor muscle with the Modified Neurotech Vital Device and that all the volunteers elicit a contraction of the pelvic floor muscle with the Neurotech Vital Device.
Contraction of the pelvic floor muscles will be assessed by using sonographic/real time ultrasound imaging/recording (mean of three measurements of pelvic floor displacement achieved during maximum threshold intensity electrical stimulation).
|
5 minutes treatment with each device to measure if contraction occurrs on the ultrasound
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Healthy Volunteers feedback questionnaires
Time Frame: after 5 minutes of treatment
|
The secondary objective of this user evaluation study is to verify that the Modified Neurotech Vital Device is perceived by the volunteers as a valid treatment option.
The Modified Neurotech Vital Device will be considered an acceptable treatment option in relation to stimulation sensation if 70% yes/not sure responses are obtained to the question 'given what you have been told about this treatment, do you believe it could be effective?'.
|
after 5 minutes of treatment
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
June 1, 2012
Primary Completion (Actual)
June 1, 2012
Study Completion (Actual)
July 1, 2012
Study Registration Dates
First Submitted
June 6, 2012
First Submitted That Met QC Criteria
June 7, 2012
First Posted (Estimate)
June 8, 2012
Study Record Updates
Last Update Posted (Estimate)
July 9, 2012
Last Update Submitted That Met QC Criteria
July 5, 2012
Last Verified
June 1, 2012
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- BMR-12-1002
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Contraction of Pelvic Floor Muscle Using EMS
-
University of Sao PauloCompletedElectric Stimulation Therapy | Pelvic Floor | Muscle | ContractionBrazil
-
Izmir University of EconomicsDokuz Eylul UniversityRecruitingPelvic Floor Muscle Training | Healthy Adult Women | Pelvic Floor Muscle ExerciseTurkey (Türkiye)
-
Federal University of São PauloCompletedCorrelation of Pelvic Floor Muscle Evaluation MethodsBrazil
-
National Cheng-Kung University HospitalRecruitingPelvic Floor Muscle Weakness | Pelvic Floor DysfunctionTaiwan
-
Eastern Mediterranean UniversityCompletedPelvic Floor Muscle WeaknessCyprus
-
Singapore General HospitalRecruitingPhysiotherapy | Pelvic Floor Dysfunction | Postpartum | Pelvic Floor Health After Childbirth | Pelvic Floor Muscle Training | Pelvic Floor Muscle Exercise | Pelvic Floor Disorder | Physiotherapy Specialty | Pelvic Floor, Obstetric | Transperineal Ultrasound | Biofeedback TherapySingapore
-
Rafia AbrarRecruitingPelvic Floor Muscle DysfunctionPakistan
-
Cigdem CinarCompleted
-
Ahi Evran University Education and Research HospitalNot yet recruitingPelvic Floor Muscle Strength MeasurementTurkey (Türkiye)
-
Okan UniversityRecruitingMuscle Strength | Pelvic Floor | Healthy WomenTurkey (Türkiye)
Clinical Trials on Modified Neurotech Vital Device
-
Bio-Medical Research, Ltd.CompletedHealthy Female VolunteersUnited States
-
Atlantic TherapeuticsCompletedStress Urinary IncontinenceGermany
-
Atlantic TherapeuticsBio-Medical Research, Ltd.CompletedStress Urinary IncontinenceUnited States
-
Johns Hopkins UniversityTerminatedCongenital Heart Disease in ChildrenUnited States
-
Hamilton Health Sciences CorporationCanadian Institutes of Health Research (CIHR); McMaster University; Population...Not yet recruitingSepsis | Post-operative Complications | Myocardial Injury After Noncardiac Surgery (MINS) | Bleeding Independently Associated With Mortality After Noncardiac Surgery (BIMS) | Infection Without SepsisCanada
-
University of Alabama at BirminghamNorthwestern University; University of Chicago; Ann & Robert H Lurie Children... and other collaboratorsNot yet recruitingTrauma | Pediatric ALL | Appendectomy | Vital Signs Monitoring
-
Northwestern UniversitySibel Health Inc.; University of Minnesota Medical School/University of Minnesota...RecruitingPatient Satisfaction | Sleep Quality | Vital Sign Monitoring | Provider Behavior | Vital Sign EvaluationUnited States
-
EarlySense Ltd.The Chaim Sheba Medical CenterWithdrawn
-
Darma Inc.Virginia Commonwealth UniversityCompletedVital Sign MonitoringUnited States
-
Duke UniversityNational Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)CompletedGlycogen Storage Disease Type IIUnited States